Making the change to area under the curve-based vancomycin dosing

被引：65

作者：

Heil, Emily L. ^{[1
,2
]}

Claeys, Kimberly C. ^{[1
,2
]}

Mynatt, Ryan P. ^{[3
]}

Hopkins, Teri L. ^{[4
]}

Brade, Karrine ^{[5
]}

Watt, Ian ^{[2
]}

Rybak, Michael J. ^{[3
,6
]}

Pogue, Jason M. ^{[7
]}

机构：

[1] Univ Maryland, Sch Pharm, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA

[2] Univ Maryland, Med Ctr, Dept Pharm, Baltimore, MD 21201 USA

[3] Detroit Receiving Hosp & Univ Hlth Ctr, Detroit Med Ctr, Dept Pharm, Detroit, MI USA

[4] South Texas Vet Hlth Care Syst, Dept Pharm, San Antonio, TX USA

[5] Boston Med Ctr, Dept Pharm, Boston, MA USA

[6] Wayne State Univ, Dept Pharm Practice, Antiinfect Res Lab, Detroit, MI USA

[7] Sinai Grace Hosp, Detroit Med Ctr, Dept Pharm, Detroit, MI USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2018年 / 75卷 / 24期

关键词：

area under the curve; minimum inhibitory concentration; pharmacodynamics; pharmacokinetics; S; aureus; vancomycin; RESISTANT STAPHYLOCOCCUS-AUREUS; INHIBITORY CONCENTRATION RATIO; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; CONCENTRATION-TIME CURVE; PHARMACOKINETICS; PHARMACODYNAMICS; EXPOSURE; OUTCOMES; ANTIMICROBIALS;

D O I：

10.2146/ajhp180034

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1986 / 1995

页数：10

共 34 条

[1] Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia [J].

不详 .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (04) :388-416

[2]

[Anonymous], 27 INT C ANT AG CHEM

[3] Evaluation of the Accuracy of a Pharmacokinetic Dosing Program in Predicting Serum Vancomycin Concentrations in Critically Ill Patients [J].

Aubron, Cecile ;

Corallo, Carmela E. ;

Nunn, Maya O. ;

Dooley, Michael J. ;

Cheng, Allen C. .

ANNALS OF PHARMACOTHERAPY, 2011, 45 (10) :1193-1198

[4] Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization [J].

Brown, Jack ;

Brown, Kristen ;

Forrest, Alan .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (02) :634-638

[5]

Carreno JJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02478-16, 10.1128/aac.02478-16]

[6] Association between Vancomycin Day 1 Exposure Profile and Outcomes among Patients with Methicillin-Resistant Staphylococcus aureus Infective Endocarditis [J].

Casapao, Anthony M. ;

Lodise, Thomas P. ;

Davis, Susan L. ;

Claeys, Kimberly C. ;

Kullar, Ravina ;

Levine, Donald P. ;

Rybak, Michael J. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) :2978-2985

[7]

Chavada R, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02535-16, 10.1128/aac.02535-16]

[8] VANCOMYCIN PHARMACOKINETICS IN A PATIENT POPULATION - EFFECT OF AGE, GENDER, AND BODY-WEIGHT [J].

DUCHARME, MP ;

SLAUGHTER, RL ;

EDWARDS, DJ .

THERAPEUTIC DRUG MONITORING, 1994, 16 (05) :513-518

[9]

Finch NA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01293-17, 10.1128/aac.01293-17]

[10] Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools [J].

Fuchs, Aline ;

Csajka, Chantal ;

Thoma, Yann ;

Buclin, Thierry ;

Widmer, Nicolas .

CLINICAL PHARMACOKINETICS, 2013, 52 (01) :9-22

← 1 2 3 4 →